Dr. Robert Meisner offers feedback on the FDA’s approval of a new ketamine product.
Keep Up With McLean!
Receive the latest news in your inbox each month.
In the Media: Clinicians Embracing New Depression Drug Esketamine With ‘Enthusiastic Caution’
March 6, 2019
